Dougherty & Co started coverage on shares of Palo Alto Networks (NASDAQ:PANW) in a research note issued on Thursday. The firm set a “buy” rating and a $95.00 price target on the stock. Palo Alto Networks Inc (NYSE:PANW) net profit margin is -39.50% and weekly performance is 4.43%. On last trading day company shares ended up $82.26. Analysts mean target price for the company is $90.15. Palo Alto Networks Inc (NYSE:PANW) distance from 50-day simple moving average is 15.94%.
NetApp (NASDAQ:NTAP) had its price objective raised by Pacific Crest from $40.00 to $41.00 in a research report released on Wednesday morning. Pacific Crest currently has an outperform rating on the stock. NetApp Inc. (NASDAQ:NTAP) shares advanced 0.25% in last trading session and ended the day on $36.61. NTAP Gross Margin is 62.00% and its return on assets is 7.00%. NetApp Inc. (NASDAQ:NTAP) quarterly performance is -0.97%.
ACADIA Pharmaceuticals (NASDAQ:ACAD) CEO Uli Hacksell sold 20,000 shares of the stock on the open market in a transaction dated Monday, June 16th. The shares were sold at an average price of $23.10, for a total transaction of $462,000.00. The sale was disclosed in a document filed with the SEC. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) shares moved up 3.67% in last trading session and was closed at $23.42, while trading in range of $22.64-$23.50. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) year to date performance is -6.28%.
Morgan Stanley assumed coverage on shares of F5 Networks (NASDAQ:FFIV) in a research note issued on Wednesday. The firm set an “equal weight” rating on the stock. F5 Networks, Inc. (NASDAQ:FFIV) ended the last trading day at $112.19. Company weekly volatility is calculated as 2.15% and price to cash ratio as 13.62. F5 Networks, Inc. (NASDAQ:FFIV) showed a positive/negative weekly performance of 2.49%.